Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 205,300 shares, a decline of 9.1% from the September 15th total of 225,800 shares. Based on an average daily volume of 249,700 shares, the short-interest ratio is presently 0.8 days.
Institutional Trading of Co-Diagnostics
An institutional investor recently raised its position in Co-Diagnostics stock. SMI Advisory Services LLC raised its stake in Co-Diagnostics, Inc. (NASDAQ:CODX – Free Report) by 117.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 38,089 shares of the company’s stock after purchasing an additional 20,590 shares during the period. SMI Advisory Services LLC owned 0.12% of Co-Diagnostics worth $43,000 as of its most recent SEC filing. Institutional investors and hedge funds own 14.99% of the company’s stock.
Co-Diagnostics Stock Up 2.5 %
Shares of Co-Diagnostics stock traded up $0.03 during trading hours on Thursday, hitting $1.25. 168,508 shares of the company’s stock traded hands, compared to its average volume of 144,005. Co-Diagnostics has a twelve month low of $1.00 and a twelve month high of $2.23. The stock has a 50 day simple moving average of $1.32 and a 200-day simple moving average of $1.25. The company has a market cap of $39.10 million, a PE ratio of -0.95 and a beta of -0.87.
Analysts Set New Price Targets
Separately, HC Wainwright decreased their target price on shares of Co-Diagnostics from $2.00 to $1.50 and set a “neutral” rating for the company in a research note on Monday, August 12th.
Read Our Latest Analysis on CODX
About Co-Diagnostics
Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.
Featured Articles
- Five stocks we like better than Co-Diagnostics
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Conference Calls and Individual Investors
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What is the S&P 500 and How It is Distinct from Other Indexes
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Co-Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Co-Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.